Evidence map›Paper›PMID 40249527›Full record

ArticleArchives of dermatological research2025

Enduring outcomes of minimally ınvasive approaches for facial rejuvenation.

Elif Sari, Aynur Aliyeva

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elif SariDepartment of Otorhinolaryngology-Head and Neck Surgery, Istanbul Aydın University VM Medikal Park Florya Hospital, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-4618-6341
Aynur AliyevaNeuroscience Doctoral Program, Yeditepe University, Istanbul, Turkey. dr.aynuraliyeva86@gmail.com.ORCID http://orcid.org/0000-0001-9398-4261

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facial rejuvenation procedures have gained popularity as individuals seek nonsurgical methods to address signs of aging. These procedures encompass a range of minimally invasive techniques, including botulinum toxin applications, dermal fillers, PRP, and thread lifting. This study aimed to assess patient satisfaction and evaluate the short- and long-term outcomes of these minimal invasive facial rejuvenation procedures. Patients aged 18-65 who underwent facial rejuvenation at an Ear, Nose, and Throat Clinic were included. Procedures had botulinum toxin applications, dermal fillers, PRP, and PDO threads. Follow-up evaluations were conducted at 4-6 months for botulinum toxin and PRP and one year for other procedures. Visual analog scales and self-satisfaction measured beauty perception data after treatments. Botulinum toxin applications effectively reduced dynamic wrinkles, while dermal fillers provided volumetric support with varying longevity. PRP improved skin tone, brightness, moisture, and fine wrinkles. Patient satisfaction levels varied across procedures. Minimal invasive facial rejuvenation procedures offer a nonsurgical approach to address aging-related concerns. Botulinum toxin, dermal fillers, PRP, and PDO threads provide unique benefits, but their outcomes and satisfaction levels differ among patients. Understanding these variations is crucial for informed decision-making in facial rejuvenation.

Indexed as

Cosmetic TechniquesDermal FillersRejuvenationSkin AgingAdolescentAdultAgedBotulinum ToxinsBotulinum Toxins, Type AFaceFemaleFollow-Up StudiesHumansMaleMiddle AgedPatient SatisfactionBotulinum ToxinsBotulinum Toxins, Type ADermal FillersBotulinum toxinDermal fillersFacial rejuvenationMinimally invasive proceduresPatient satisfactionPDO threadsPRP

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.